Interferon gamma in rheumatoid arthritis--a double blind study comparing human recombinant interferon gamma with placebo

Affiliations

PMID: 3135392

Clinical Trial

E M Veys et al. J Rheumatol. 1988 Apr.

Abstract

A double blind trial comparing recominant interferon gamma (IFN gamma) with placebo in rheumatoid arthritis is presented. Twenty-six patients entered the study and 22 completed the 6-month period. IFN gamma was administered subcutaneously as was placebo; the 1st week, patients treated with the active compound received a daily subcutaneous injection of 100 micrograms of IFN gamma and for the following 23 weeks the schedule was decreased to 2 injections of 100 micrograms every week. No serious side effects were observed. After Week 24 the group treated with the active compound showed a significant decrease of the joint tenderness score and the placebo group showed a significant increase of the number of subcutaneous nodules. All other variables shifted in favour of the active compound but not significantly. More double blind trials with a larger number of patients and using other treatment schedules or other routes of administration are required.

PubMed Disclaimer

Cited by

Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed joint.
Grieshaber-Bouyer R, Exner T, Hackert NS, Radtke FA, Jelinsky SA, Halyabar O, Wactor A, Karimizadeh E, Brennan J, Schettini J, Jonsson H, Rao DA, Henderson LA, Müller-Tidow C, Lorenz HM, Wabnitz G, Lederer JA, Hadjipanayis A, Nigrovic PA. Grieshaber-Bouyer R, et al. Ann Rheum Dis. 2022 Jun;81(6):805-814. doi: 10.1136/annrheumdis-2021-221866. Epub 2022 Feb 15. Ann Rheum Dis. 2022. PMID: 35168946 Free PMC article.
Chemotaxis of Vδ2 T cells to the joints contributes to the pathogenesis of rheumatoid arthritis.
Mo WX, Yin SS, Chen H, Zhou C, Zhou JX, Zhao LD, Fei YY, Yang HX, Guo JB, Mao YJ, Huang LF, Zheng WJ, Zhang W, Zhang JM, He W, Zhang X. Mo WX, et al. Ann Rheum Dis. 2017 Dec;76(12):2075-2084. doi: 10.1136/annrheumdis-2016-211069. Epub 2017 Sep 2. Ann Rheum Dis. 2017. PMID: 28866647 Free PMC article.
Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenase.
Gonzalo-Gil E, Pérez-Lorenzo MJ, Galindo M, Díaz de la Guardia R, López-Millán B, Bueno C, Menéndez P, Pablos JL, Criado G. Gonzalo-Gil E, et al. Arthritis Res Ther. 2016 Apr 1;18:77. doi: 10.1186/s13075-016-0979-0. Arthritis Res Ther. 2016. PMID: 27036118 Free PMC article.
Possible roles of IL-12-family cytokines in rheumatoid arthritis.
Pope RM, Shahrara S. Pope RM, et al. Nat Rev Rheumatol. 2013 Apr;9(4):252-6. doi: 10.1038/nrrheum.2012.170. Epub 2012 Oct 23. Nat Rev Rheumatol. 2013. PMID: 23090510 Free PMC article. Review.
Exposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiation.
Huang W, O'Keefe RJ, Schwarz EM. Huang W, et al. Arthritis Res Ther. 2003;5(1):R49-59. doi: 10.1186/ar612. Epub 2002 Nov 12. Arthritis Res Ther. 2003. PMID: 12716453 Free PMC article.

Interferon gamma in rheumatoid arthritis--a double blind study comparing human recombinant interferon gamma with placebo - PubMed (original) (raw)